SG
DGX icon

Societe Generale’s Quest Diagnostics DGX Stock Holding History

Societe Generale’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$6.44M Buy
+79,070
New +$6.02M 0.05% 326

Other funds holding DGX

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Societe Generale's DGX Position: Q2 2016 in Review

Societe Generale opened a new position in Quest Diagnostics (DGX) in Q2 2016: 79,070 shares worth $6.44M. The stake represents 0.05% of the portfolio and ranks #326 among its holdings.

558 funds tracked by Wall St. Rank hold DGX as of Q2 2016.

  • Societe Generale held 79,070 shares of Quest Diagnostics worth $6.44M as of Q2 2016.
  • Quest Diagnostics was a new Societe Generale position in Q2 2016.
  • Quest Diagnostics made up 0.05% of Societe Generale's portfolio in Q2 2016, its #326 holding.
  • 558 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.